😎 Sommerzeit, Hammer-Deals! Bei InvestingPro winken jetzt bis zu 50% Rabatt auf KI-Aktien-TippsJETZT ZUGREIFEN

DGAP-News: Analogic Showcases Three New BK Medical Ultrasound Systems With Groundbreaking Quantum Technology at EAU Congress (deutsch)

Veröffentlicht am 22.02.2012, 20:00
Analogic Showcases Three New BK Medical Ultrasound Systems With Groundbreaking Quantum Technology at EAU Congress

Analogic Corporation

22.02.2012 20:00

---------------------------------------------------------------------------

New Quantum Technology Offers Exceptional Image Quality; Streamlines Workflow

PEABODY, Mass., 2012-02-22 20:00 CET (GLOBE NEWSWIRE) --

Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and

aviation security technology, today announced that it will showcase for the

first time its new Flex Focus(tm) 500, Flex Focus 800, and Pro Focus(tm) UltraView

800 BK Medical ultrasound systems at the 27th annual European Association of

Urology (EAU) Congress in Paris. The new BK Medical ultrasound systems

incorporate the groundbreaking Quantum(tm) Technology, offering significant new

features and advancements to improve the practice of medicine. The new

ultrasound systems with Quantum Technology were publicly announced worldwide to

customers last month.

'The new BK Medical ultrasound solutions provide clinicians a faster and easier

way to maximize ultrasound performance, specifically in urology and renal

imaging,' said Lars Shaw, vice president of global marketing at Analogic. 'The

superb imaging performance and dramatic increase in 2D and color Doppler

capabilities, coupled with the productivity enhancements built into the new

Quantum Technology, are examples of our dedication and promise to provide

leading-edge ultrasound systems.

'We can now offer our customers excellent 2D imaging to visualize kidney

anatomy out to the pyramids and capsule. With the Quantum Technology release,

our sensitive color Doppler routinely visualizes blood flow out to the arcuate

arteries,' continued Shaw.

Quantum Technology offers image quality enhancements including improved

contrast resolution, as well as new gray scale maps and new image pre-sets,

making it easier and quicker to obtain the highest quality images. In addition,

the new technology includes a unique Vector Flow Imaging (VFI) mode*, enabling

angle independent visualization of blood flow, and an advanced color Doppler

mode, enabling superb spatial resolution. Key benefits also include advanced

harmonic imaging when imaging all patient types, even the extremely

difficult-to-image patient.

Analogic's three new ultrasound systems complement BK Medical's extensive

product portfolio. The Flex Focus 800 and UltraView 800 are premium

performance, highly efficient new systems that incorporate Quantum Technology.

Compatible with all of BK Medical's transducers, the fully featured, premium

performance systems are ideally suited for surgery, including robotic-assisted

surgery, high-end urology, and general imaging. The UltraView 800 system also

has contrast imaging capabilities**, and both the Flex Focus 800 and UltraView

800 systems have a HistoScanning*** ready option. The Flex Focus 500 is the

mid-range system in the BK Medical family incorporating Quantum Technology.

This portable system is powerful and well suited for a busy practice utilizing

ultrasound for urology and general imaging needs. All of the new systems also

have VFI* as an option. The full BK Medical product portfolio includes the Flex

Focus 200, 200 Surgery, 400 Anesthesia, 700, and the Pro Focus UltraView.

To see a live demonstration of the three new ultrasound systems with Quantum

Technology, please visit the BK Medical booth #2M34 during the EAU Congress,

February 24-28, 2012.

About Analogic and the BK Medical brand

Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology

solutions to advance the practice of medicine and save lives. Analogic's

ultrasound group designs and manufactures ultrasound systems and specialized

transducers that are sold directly to medical practitioners under the BK

Medical brand. For over 30 years, our market-leading BK Medical branded

ultrasound solutions have been used to improve the practice of medicine in

procedure-driven markets such as urology, surgery and anesthesia. BK Medical's

products, including our award-winning Flex Focus family of systems and unique

transducer designs, offer advanced imaging capabilities that enable real-time

image guidance in an easy-to-use, portable platform. Our Analogic ultrasound

group has operations in Massachusetts, Pennsylvania, Colorado, Denmark, and

Shanghai.

For more information on our BK Medical ultrasound products visit www.bkmed.com.

For more information on Analogic, visit www.analogic.com.

* VFI is not licensed by Health Canada and is FDA cleared for the

Ultraview 800.

** Contrast imaging capabilities are FDA cleared for cardiac applications

only.

*** HistoScanning is not an FDA market cleared application or licensed by

Health Canada.

Analogic is a registered trademark of Analogic Corporation.

The globe logo is a trademark of Analogic Corporation.

CONTACT: Media Contact:

Amy Cook

(925) 552-7893

amycook@amcpublicrelations.com



Investor Contact:

Mark Namaroff

Director of Investor Relations & Corporate Marketing

(978) 326-4058

investorrelations@analogic.com

News Source: NASDAQ OMX

22.02.2012 Dissemination of a Corporate News, transmitted by DGAP -

a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------



Language: English

Company: Analogic Corporation





United States

Phone:

Fax:

E-mail:

Internet:

ISIN: US0326572072

WKN:



End of Announcement DGAP News-Service



---------------------------------------------------------------------------

Aktuelle Kommentare

Installieren Sie unsere App
Risikohinweis: Beim Handel mit Finanzinstrumenten und/oder Kryptowährungen bestehen erhebliche Risiken, die zum vollständigen oder teilweisen Verlust Ihres investierten Kapitals führen können. Die Kurse von Kryptowährungen unterliegen extremen Schwankungen und können durch externe Einflüsse wie finanzielle, regulatorische oder politische Ereignisse beeinflusst werden. Durch den Einsatz von Margin-Trading wird das finanzielle Risiko erhöht.
Vor Beginn des Handels mit Finanzinstrumenten und/oder Kryptowährungen ist es wichtig, die damit verbundenen Risiken vollständig zu verstehen. Es wird empfohlen, sich gegebenenfalls von einer unabhängigen und sachkundigen Person oder Institution beraten zu lassen.
Fusion Media weist darauf hin, dass die auf dieser Website bereitgestellten Kurse und Daten möglicherweise nicht in Echtzeit oder vollständig genau sind. Diese Informationen werden nicht unbedingt von Börsen, sondern von Market Makern zur Verfügung gestellt, was bedeutet, dass sie indikativ und nicht für Handelszwecke geeignet sein können. Fusion Media und andere Datenanbieter übernehmen daher keine Verantwortung für Handelsverluste, die durch die Verwendung dieser Daten entstehen können.
Die Nutzung, Speicherung, Vervielfältigung, Anzeige, Änderung, Übertragung oder Verbreitung der auf dieser Website enthaltenen Daten ohne vorherige schriftliche Zustimmung von Fusion Media und/oder des Datenproviders ist untersagt. Alle Rechte am geistigen Eigentum liegen bei den Anbietern und/oder der Börse, die die Daten auf dieser Website bereitstellen.
Fusion Media kann von Werbetreibenden auf der Website aufgrund Ihrer Interaktion mit Anzeigen oder Werbetreibenden vergütet werden.
Im Falle von Auslegungsunterschieden zwischen der englischen und der deutschen Version dieser Vereinbarung ist die englische Version maßgeblich.
© 2007-2024 - Fusion Media Limited. Alle Rechte vorbehalten.